Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420803 · ClinicalTrials.gov registry record · NA
A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
A NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07420803: Recruiting NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness, sponsored by Mayo Clinic.
NCT07420803 is a NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420803, a NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with aurical transcutaneous vagus nerve stimulation (aTVNS).
Conditions Studied
Interventions
- OTHER Sham Device
- OTHER Auricular transcutaneous vagus nerve stimulation
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07420803
The ClinicalTrials.gov registry entry for NCT07420803 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Dizziness appearing as the primary indexed condition, and to 2 interventions - of which Sham Device is the first listed.
NCT07420803 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07420803 about?
NCT07420803 is a clinical study titled "A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness". The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with aurical transcutaneous vagus nerve stimulation (aTVNS).
What is the current status of trial NCT07420803?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03. Estimated completion is 2027-03.
What conditions does trial NCT07420803 study?
This clinical trial studies the following conditions: Chronic Dizziness, Persistent Postural Perceptual Dizziness.
What interventions are being tested in trial NCT07420803?
The interventions under investigation include: Sham Device (OTHER), Auricular transcutaneous vagus nerve stimulation (OTHER).
Who is sponsoring clinical trial NCT07420803?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07420803 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.